Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-13

Clinical Trial Update: Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial for Chronic Fatigue Syndrome described as a presumptive mitochondrial disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Chronic Fatigue Syndrome | Phase 2 | Status: WITHDRAWN